In response to new business models, accelerated timelines, and unforeseen market dynamics, healthcare companies are seeking to innovate rapidly and effectively to meet new challenges. A key criterion for success is the adoption of cutting-edge tools that derisk and accelerate the drug development process. Investment in these tools pays dividends across a company's pipeline.
Join MIT's global community at the 2024 MIT Research and Development Conference on November 19-20, 2024, to explore groundbreaking innovations in AI, mobility, life sciences, space tech, microelectronics, and quantum computing and celebrate the 40th anniversary of the Microsystems Technology Laboratories (MTL).
Andrés Bisonó León CEO and Co-Founder, SOS Carbon
Contact
Assistant
Principal Investigator Zahra Kanji